>
Curaleaf Holdings Inc logo

CURA - Curaleaf Holdings Inc Share Price

C$17.4 -0.1  -0.7%

Last Trade - 16/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £6.68bn
Enterprise Value £7.05bn
Revenue £453.1m
Position in Universe 69th / 2713
Bullish
Bearish
Unlock CURA Revenue
Momentum
Relative Strength (%)
1m -13.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -25.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 77.1 221 626.6 1,257 1,806
+296
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, CuraleafHoldings Inc revenues increased from $221M to $626.6M. Netloss decreased 8% to $61.7M. Revenues reflect Cannabissegment increase from $173.9M to $586.2M. Lower net lossreflects Cannabis segment income totaling $122.2M vs. lossof $6.3M. Basic Earnings per Share excluding ExtraordinaryItems increased from -$0.15 to -$0.11.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CURA Revenue Unlock CURA Revenue

Net Income

CURA Net Income Unlock CURA Revenue

Normalised EPS

CURA Normalised EPS Unlock CURA Revenue

PE Ratio Range

CURA PE Ratio Range Unlock CURA Revenue

Dividend Yield Range

CURA Dividend Yield Range Unlock CURA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CURA EPS Forecasts Unlock CURA Revenue
Profile Summary

Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. The Company is focused on research and development capabilities to distribute cannabis products. The Company operates in 23 states with 103 dispensaries, 22 cultivation sites and 30 processing sites. It provides service, selection, and accessibility across the medical and adult-use markets, as well as the cannabidiol (CBD) category through its Curaleaf Hemp brand. It owns and operates a number of dispensaries, cultivation sites and processing sites with a focus on limited license states, including Florida, Massachusetts, New Jersey and New York.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 13, 2014
Public Since October 22, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Canadian Securities Exchange
Shares in Issue 663,801,845
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CURA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CURA
Upcoming Events for CURA
Frequently Asked Questions for Curaleaf Holdings Inc
What is the Curaleaf Holdings Inc share price?

As of 16/04/21, shares in Curaleaf Holdings Inc are trading at C$17.4, giving the company a market capitalisation of £6.68bn. This share price information is delayed by 15 minutes.

How has the Curaleaf Holdings Inc share price performed this year?

Shares in Curaleaf Holdings Inc are currently trading at C$17.4 and the price has moved by 0.222k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Curaleaf Holdings Inc price has moved by 0.139k% over the past year.

What are the analyst and broker recommendations for Curaleaf Holdings Inc?

Of the analysts with advisory recommendations for Curaleaf Holdings Inc, there are there are currently 4 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Curaleaf Holdings Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Curaleaf Holdings Inc next release its financial results?

Curaleaf Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Curaleaf Holdings Inc dividend yield?

Curaleaf Holdings Inc does not currently pay a dividend.

Does Curaleaf Holdings Inc pay a dividend?

Curaleaf Holdings Inc does not currently pay a dividend.

When does Curaleaf Holdings Inc next pay dividends?

Curaleaf Holdings Inc does not currently pay a dividend.

How do I buy Curaleaf Holdings Inc shares?

To buy shares in Curaleaf Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Curaleaf Holdings Inc?

Shares in Curaleaf Holdings Inc are currently trading at C$17.4, giving the company a market capitalisation of £6.68bn.

Where are Curaleaf Holdings Inc shares listed? Where are Curaleaf Holdings Inc shares listed?

Here are the trading details for Curaleaf Holdings Inc:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: CURA
What kind of share is Curaleaf Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Curaleaf Holdings Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Curaleaf Holdings Inc share price forecast 2021?

Shares in Curaleaf Holdings Inc are currently priced at C$17.4. At that level they are trading at 60.37% discount to the analyst consensus target price of 0.00.

Analysts covering Curaleaf Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.075221929 for the next financial year.

How can I tell whether the Curaleaf Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curaleaf Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 26.67%. At the current price of C$17.4, shares in Curaleaf Holdings Inc are trading at 19.72% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Curaleaf Holdings Inc PE Ratio?

We were not able to find PE ratio data for Curaleaf Holdings Inc.

Who are the key directors of Curaleaf Holdings Inc?

Curaleaf Holdings Inc's management team is headed by:

Boris Jordan - CHM
Joseph Lusardi - VCH
Karl Johansson - IND
Peter Clateman - GCN
Joseph Bayern - PRE
Talley Wettlaufer - SVP
Jaswinder Grover - IND
Peter Derby - IND
Mitchell Kahn - IND
Jim Shorris - CCO
Michael Carlotti - CFO
Jason White - CMO
Neil Davidson - COO
Carlos Madrazo - SVP
Who are the major shareholders of Curaleaf Holdings Inc?

Here are the top five shareholders of Curaleaf Holdings Inc based on the size of their shareholding:

Blokh (Andrei) Individual Investor
Percentage owned: 21.54% (127.2m shares)
Jordan (Boris) Individual Investor
Percentage owned: 9.78% (57.7m shares)
Kahn (Mitchell Phillip) Individual Investor
Percentage owned: 0.95% (5.61m shares)
Grover (Jaswinder) Individual Investor
Percentage owned: 0.92% (5.45m shares)
Lusardi (Joseph F.) Individual Investor
Percentage owned: 0.9% (5.30m shares)
Similar to CURA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.